Proactive Investors - Run By Investors For Investors

Holista CollTech to file patent for world’s first all-natural low-GI sugar

Holista CollTech (ASX:HCT) has collaborated with 2017 Nobel Prize nominee Daryl Thompson to file a patent for the world’s first low glycemic index (GI) sugar made out of all-natural ingredients.
Holista CollTech to file patent for world’s first all-natural low-GI sugar
Holista’s shares were last trading at $0.135, up 28.6% intra-day.

Daryl Thompson is an emerging thought leader in carbohydrate chemistry who was nominated for the 2015 and 2016 Nobel Prize.

Holista’s shares were last trading at $0.135, up 28.6% intra-day.

The all-natural, low-GI sugar is the newest addition to Holista’s low-GI suite of products.

The formula is being refined before testing at the world renowned GI Labs in Toronto for final validation.

As the product is made from natural ingredients, it is unlikely to face regulatory hurdles.

Holista expects to launch the product before June 2017.

High-GI foods are rapidly and easily converted to sugar, causing spikes in blood sugar levels that can lead to heart disease, diabetes and obesity over time.

Unlike other alternatives which can only be used in beverages, such as artificial sweeteners, Holista’s natural low-GI sugar can be melted, baked and caramelized for use in all cooking applications.

When consumed, it reduces the rate that glucose is digested throughout the body.

A 2012 study in the highly acclaimed scientific journal Nature suggested that sugar should be considered as toxic as other substances harmful to public health, such as alcohol or tobacco.

The authors urged government regulation to curb consumption, including taxes, advertisement restrictions, and even age requirements for purchase of sugary foods.

View full HCT profile View Profile

Holista Colltech Ltd Timeline

Newswire
September 19 2017

Related Articles

Scientist
December 03 2018
Since September, the group's portfolio has steamed ahead with a number of new and successful clinical trials, as well as a boost from the float of one of its companies on the Nasdaq
cholesterol on a dial
September 24 2018
"The formation of ProBiotix Health and appointment of Adam Reynolds as chairman continues a successful strategy of building value in each division which is materialised by forming separate legal entities and taking them to a public listing,” said chief executive Stephen O’Hara
CBD oil
November 16 2018
The company’s technology creates nano-scale emulsion mixtures that allow fluids to mix that normally don’t mix, such as CBD oil and water

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use